6412:TSEHeiwa Corporation Analysis
Data as of 2026-03-17 - not real-time
¥1,931.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Heiwa Corp (6412.T) is trading at ¥1,931, essentially hugging its 20‑day SMA of ¥1,983 and sitting just above a key support level of ¥1,930, while the 50‑day and 200‑day SMAs sit higher at ¥2,017 and ¥2,062, confirming a short‑term bearish bias. Technical signals are mixed: the RSI of 35 suggests the stock is oversold, yet the MACD histogram remains negative and the MACD line sits below its signal, reinforcing bearish momentum. Volatility is modest at 13.5% over the past 30 days and beta is very low at 0.25, indicating limited price swings relative to the market. Fundamentally, the company boasts a staggering 59.8% revenue growth and an operating margin of 26.4%, while its DCF‑derived fair value of ¥7,684 implies roughly 40% upside from current levels. The dividend yield of 4.13% with a 63% payout ratio appears sustainable given strong free cash flow, but the balance sheet is heavily leveraged (debt‑to‑equity ≈ 245) which tempers optimism.
Overall, the stock is deeply undervalued relative to its intrinsic value and growth trajectory, offering a compelling entry point for value‑oriented investors, yet the high leverage and sector‑specific regulatory exposure introduce material risk. The consensus analyst rating of “strong buy” aligns with the upside potential, but investors should monitor debt levels and any regulatory changes affecting the pachinko industry.
Overall, the stock is deeply undervalued relative to its intrinsic value and growth trajectory, offering a compelling entry point for value‑oriented investors, yet the high leverage and sector‑specific regulatory exposure introduce material risk. The consensus analyst rating of “strong buy” aligns with the upside potential, but investors should monitor debt levels and any regulatory changes affecting the pachinko industry.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Price near strong support level
- Attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial revenue growth (~60%)
- Significant valuation gap to DCF fair value
- Sustainable dividend supported by cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term upside to intrinsic value
- Low market beta reducing systematic risk
- Consistent cash generation despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth59.80%
P/E Ratio15.3
ROE3.78%
ROA3.38%
Debt/Equity244.94
P/B Ratio0.8
Op. Cash Flow¥37.3B
Free Cash Flow¥34.7B
Technical Analysis
TrendBearish
RSI35.0
Support¥1,930.00
Resistance¥2,020.00
MA 20¥1,983.15
MA 50¥2,017.14
MA 200¥2,062.11
MACDBearish
VolumeIncreasing
Fear & Greed Index79.43
Valuation
Fair Value¥7,684.37
Target Price¥2,740.00
Upside/Downside41.90%
GradeUndervalued
TypeGrowth
Dividend Yield4.13%
Risk Assessment
Beta0.25
Volatility13.46%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.